(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IPTILBY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

IPTILBY

ST13

US500000079440400

Class

5

Filing

79440400

Registration

8209131

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

05/15/2026

Trademark type

Combined

Nice classes

5

Filing date

11/12/2025

Registration date

04/14/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/14/2026

Last transaction

05/15/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

25

Owner location

Basel, CH

Examiner

RIBAUDO, MICHELLE RACHEL

Law office

N80

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Novartis AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Publications

History of USPTO decisions and trademark events.

26 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/14/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/14/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

04/14/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/25/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/25/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/25/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/25/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/25/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/25/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/24/2026

PUBO

PUBLISHED FOR OPPOSITION

02/24/2026

GPNX

NOTIFICATION PROCESSED BY IB

02/19/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/18/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/04/2026

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/03/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/27/2026

DOCK

ASSIGNED TO EXAMINER

01/25/2026

MAFR

APPLICATION FILING RECEIPT MAILED

01/16/2026

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/16/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

01/13/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/13/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/13/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/13/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/13/2026

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

01/11/2026

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/01/2026

Continuous trademark protection

Get notified about every new filing that threatens IPTILBY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.